An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients

por Ichikawa, W, Uehara, K, Minamimura, K, Tanaka, C, Takii, Y, Miyauchi, H, Sadahiro, S, Fujita, K, Moriwaki, T, Nakamura, M, Takahashi, T, Tsuji, A, Shinozaki, K, Morita, S, Ando, Y, Okutani, Y, Sugihara, M, Sugiyama, T, Ohashi, Y, Sakata, Y
Publicado 2015

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

por Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Publicado 2012

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

por Yoshida, M., Ishiguro, M., Ikejiri, K., Mochizuki, I., Nakamoto, Y., Kinugasa, Y., Takagane, A., Endo, T., Shinozaki, H., Takii, Y., Mochizuki, H., Kotake, K., Kameoka, S., Takahashi, K., Watanabe, T., Watanabe, M., Boku, N., Tomita, N., Nakatani, E., Sugihara, K.
Publicado 2014